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Stress of impaired relaxationIschemic heart disease (IHD) remains the number one cause of
death worldwide [1], though promising strides in both IHD diag-
nosis and management have improved this outlook in recent de-
cades. In the United States alone age-adjusted IHD mortality rates
have steadily declined since the 1960's, owing primarily to the
treatment of atherosclerosis and its risk factors [2]. Consequently,
current approaches to IHD diagnosis have largely shifted towards
coronary atherosclerosis as a central etiology. Yet we now recognize
that atherosclerosis alone is neither necessary nor sufﬁcient to
account for signs and symptoms of IHD in many patients. For
example, 10e30% of patients with typical angina have no evidence
of obstructive atherosclerosis at invasive angiography [3].
Conversely, obstructive atherosclerosis by anatomical testing has
poor correlation with both the presence of functional ischemia and
patient symptoms. Thus, the ischemic cascade can no longer be
associated exclusively with obstructive coronary atherosclerosis,
but may result from a number of mechanisms to include endo-
thelial dysfunction and coronary vasospasm [4] (Fig. 1).
As shown in Fig. 1, myocardial ischemia results when there is an
imbalance between myocardial demand for oxygen and its supply.
Subsequently, transient or ﬁxed electrocardiogram (ECG) changes,
diastolic and/or systolic dysfunction may develop depending on
multiple factors including the size/location, duration and extent of
hypoperfusion (e.g., subendocardial vs transmural). Importantly,DOI of original article: http://dx.doi.org/10.1016/j.atherosclerosis.2014.07.009.
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with other IHD mechanisms. Not shown in Fig. 1, however, is the
contribution of a 50e70% blood ﬂow pressure drop across the high
resistance small arteries, with an ability of small caliber arterioles
to maintain constant capillary ﬂow despite variations in arterial
blood pressure. At this level, endothelial dysfunction resulting in
abnormal smooth muscle tone and response to stretch (e.g., the
Bayliss effect e most prominent in arterioles) has potential to
impact myocardial perfusion both at rest and during periods of
stress. This idea forms the basis for acetylcholine (ACh) testing,
which results in vasodilation in normal vessels, but paradoxic
vasoconstriction at sites of impaired endothelial dysfunction by
impaired release of nitric oxide. This simpliﬁed model demon-
strates what amounts to a complicated interplay of IHD patho-
physiology with an ability to target disease-speciﬁc mechanisms.
In a recent issue of Atherosclerosis, Dr. Arrebola-Moreno and
colleagues take a signiﬁcant step in understanding IHD patho-
physiology among patients with chronic stable angina in the
absence of obstructive coronary artery plaque [5]. In this selected
population, acetylcholine (ACh) testing was used to demonstrate
associations between microvascular spasm, myocardial ischemia,
and changes in left ventricular contractile function.
While several studies have documented decreased coronary
blood ﬂow in patients undergoing acetylcholine (ACh) testing, few
have successfully linked functional impairment in blood supply to
myocardial ischemia and associated diastolic dysfunction. Proposed
reasons for this missed connection [6], with importance to ﬁndings
by Dr. Arrebola-Morena et al., include:
(1) Acetylcholine dose
Previous protocols for ACh dosing typically use  100 ug [7],
while the current study demonstrates a majority of patient re-
sponses at higher doses of Ach (n ¼ 30/31 responded to
100e200 ug). Though high doses of ACh may be expected to limit
test speciﬁcity, their ﬁndings challenge traditional ACh protocols,
which would have “missed” 45% (n ¼ 14/31) of vasospastic re-
sponses in this study. Importantly, as ACh can have nonspeciﬁc
effects on endothelium-dependent vasodilatation and action as a
direct vasoconstrictor, the exact mechanism accounting for theser the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Ischemic Cascade. Note that an imbalance of oxygen supply and demand may
result from co-existing or independent triggers of myocardial ischemia. ECG,
electrocardiogram.
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variant angina at more physiologic ACh levels.
(2) Limitations of methods used to detect ischemia
Previous deﬁnition of an ACh response by Mohri et al. [8] and
others relies on typical angina symptoms and ischemic ECG
changes during ACh infusion (combined with angiographic ﬁnd-
ings) to detect epicardial and microvascular ischemia. As ECG
changes provide limited sensitivity for this purpose, it seems ﬁtting
to expand our study of ACh response to include more sensitive
markers of ischemia. This study adds echocardiographic changes in
diastolic function (change in deceleration time, E/A, or E wave
downslope), or a 20% increase in ultrasensitive cardiac troponin
(US-cTn) to deﬁne a positive ACh response. As expected, all diastolic
echo parameters and US-cTn changes demonstrated higher sensi-
tivity to predict a positive ACh test compared to ECG ﬁndings at the
expense of variable speciﬁcity.
(3) Intermittent nature of microvascular disease
Coronary tone, patient symptoms and responses to ACh testing
can vary markedly. Indeed, diurnal variations in endothelial func-
tion and the timing of ischemia have been demonstrated in patients
with variant angina [9]. Additionally, risk factors for vasospasm
(e.g., age, gender, myocardial bridging) may contribute to between-
patient responses, and further study is needed to examinevariations in response to ACh testing and changes resulting from
patient management.
Of particular novelty in the current study is the observation that
coronary vasospasm of the microvasculature may cause regional
dysfunction, and is associated with an increase in US-cTn. Given
that >10% of patients presenting to the emergency department
with elevated US-cTn levels will have normal or non-obstructive
CAD [10], it will be important to understand the actual preva-
lence of vasoconstriction across clinical settings as a potential cause
of ischemia. Further, while the current analysis excluded patients
with obstructive atherosclerosis, there is no reason to believe that
plaque “protects” the distal vascular bed from endothelial or
microvascular dysfunction and likely contributes to these mecha-
nisms. To this end, the true prevalence of microvascular spasm
remains unknown and further work is needed to build on the
important contributions by Dr. Arrebola-Moreno and colleagues.Disclosures
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